Venus Commercial Co
Venus Commercial Co
Venus Commercial Co
vs
FACTS:
In a letter dated April 7, 2014 received by the FDA from Ecowaste Coalition, it alleged that the
Artex Fine Water Colors manufactured by petitioner Venus Commercial Co., have high lead
content. Acting thereon, FDA purchased samples of Artex Fine Water Colors and subjected them
to laboratory analysis. The results showed that the amount of lead in each sample exceeded the
maximum tolerable limits prescribed by FDA. Verification with the records of this Office also
shows that the aforesaid establishment has no valid license to operate as
manufacturer/distributor of the questioned product.
Consequently, the FDA Acting Director-General issued FDA Personnel Order No. 2014-220
granting authority for Food and Drug Regulation Officers of the RFO-NCR to proceed and enter
Venus Commercial Company, Inc. located at 10 University Ave., Malabon City, conduct
inspection, and if confirmed manufacturing and/or distributing Artex Fine Water Colors, to seize
the same and/or padlock the establishment.
On May 29, 2014, FDA agents went to petitioner's office in Malabon City to implement the said
FDA Order but weren’t allowed in by the security. The FDA agents left, but not without first
serving Venus a Notice of Violation Report. They also advised the company that they would
return to implement the Order on another date.
A few days later, or on June 4, 2014, Venus filed a petition for certiorari and prohibition with
application for writ of preliminary injunction and/or temporary restraining order (TRO). Among
other things, Venus assailed Section 10(ff) of the RA 3720, as amended, for being supposedly an
undue delegation of legislative power.
In its Decision, the trial court stated that it avoided the issue of constitutionality and focused
solely on the factual basis of FDA Personnel Order No. 2014-220. It ruled that since there was no
showing that laboratory tests were actually done on the product samples, the right of Venus to
due process was violated, hence, the impugned FDA Personnel Order No. 2014-220 is void.
Respondents brought the same to the appellate court, in its Decision the Court of Appeals
reversed and consequently dissolved the writ of permanent injunction. Hence, this petition.
ISSUE:
RULINGS:
The Court has adopted two (2) tests in determining whether a statute is validly delegated or not,
to wit: the completeness test and the sufficient standard test. Under the first test, the law must
be complete in all its terms and conditions when it leaves the legislature such that when it
reaches the delegate, the only thing he or she will have to do is to enforce it. The second test or
the sufficient standard test, mandates that there should be adequate guidelines or limitations in
the law to determine the boundaries of the delegate's authority and prevent the delegation from
running riot.
RA 3720, as amended, is complete in itself such that Section 3 thereof sets forth the policy to be
carried out or implemented by the delegate, the FDA. Furthermore, the law fixes a standard and
the limits of such standards are sufficiently determinate or determinable. Consistent with the
State policy to protect and promote the right to health of the Filipino people and maintain an
effective health products regulatory system, the legislature strengthened the FDA's regulatory
power over "health products” by virtue of Sec. 10 (ff) of the same law. Whether the final
sentence of Section 10 (ff) gave the FDA unbridled authority to determine what constitutes a
health product, hence, void, is wholly immaterial here. Just the same, petitioner's Artex Fine
Water Colors would still be classified as "health products" within the regulatory jurisdiction of the
FDA for it still squarely falls under "household/urban hazardous substances" as defined in Section
10 (gg) of RA 3720.
Therefore, the Court ruled that there is no undue delegation of legislative power in this case.